152 related articles for article (PubMed ID: 21723276)
1. 5-HT(1A) receptor sensitivity in 5-HT(1B) receptor KO mice is unaffected by chronic fluvoxamine treatment.
Vinkers CH; Groenink L; Pattij T; Olivier B; Bouwknecht JA
Eur J Pharmacol; 2011 Sep; 667(1-3):250-7. PubMed ID: 21723276
[TBL] [Abstract][Full Text] [Related]
2. Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice.
de Groote L; Olivier B; Westenberg HG
Psychopharmacology (Berl); 2002 Aug; 162(4):419-24. PubMed ID: 12172696
[TBL] [Abstract][Full Text] [Related]
3. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.
De Groote L; Olivier B; Westenberg HG
Eur J Pharmacol; 2002 Mar; 439(1-3):93-100. PubMed ID: 11937097
[TBL] [Abstract][Full Text] [Related]
4. 5-HT(1B) receptor knockout mice show no adaptive changes in 5-HT(1A) receptor function as measured telemetrically on body temperature and heart rate responses.
Bouwknecht JA; Hijzen TH; van der Gugten J; Maes RA; Hen R; Olivier B
Brain Res Bull; 2002 Jan; 57(1):93-102. PubMed ID: 11827741
[TBL] [Abstract][Full Text] [Related]
5. Characterization of 5-HT(1A/1B)-/- mice: an animal model sensitive to anxiolytic treatments.
Guilloux JP; David DJ; Xia L; Nguyen HT; Rainer Q; Guiard BP; Repérant C; Deltheil T; Toth M; Hen R; Gardier AM
Neuropharmacology; 2011 Sep; 61(3):478-88. PubMed ID: 21333660
[TBL] [Abstract][Full Text] [Related]
6. 5-HT 1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT 1A and 5-HT 1B knockout mice.
Monaca C; Boutrel B; Hen R; Hamon M; Adrien J
Neuropsychopharmacology; 2003 May; 28(5):850-6. PubMed ID: 12637954
[TBL] [Abstract][Full Text] [Related]
7. Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.
Millan MJ; Veiga S; Girardon S; Brocco M
Psychopharmacology (Berl); 2003 Aug; 168(4):397-409. PubMed ID: 12721776
[TBL] [Abstract][Full Text] [Related]
8. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
Zhang H; Wang W; Jiang Z; Shang J; Zhang L
Arzneimittelforschung; 2010; 60(3):109-15. PubMed ID: 20422941
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the 5-HT(1A) receptor in the anti-immobility effects of fluvoxamine in the forced swimming test and mouse strain differences in 5-HT(1A) receptor binding.
Sugimoto Y; Furutani S; Kajiwara Y; Hirano K; Yamada S; Tagawa N; Kobayashi Y; Hotta Y; Yamada J
Eur J Pharmacol; 2010 Mar; 629(1-3):53-7. PubMed ID: 19958758
[TBL] [Abstract][Full Text] [Related]
10. Juvenile 5HT(1B) receptor knockout mice exhibit reduced pharmacological sensitivity to 5HT(1A) receptor activation.
El-Khodor BF; Dimmler MH; Amara DA; Hofer M; Hen R; Brunner D
Int J Dev Neurosci; 2004; 22(5-6):405-13. PubMed ID: 15380839
[TBL] [Abstract][Full Text] [Related]
11. Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT(1A) receptor-adenylyl cyclase axis.
Stewart A; Maity B; Wunsch AM; Meng F; Wu Q; Wemmie JA; Fisher RA
FASEB J; 2014 Apr; 28(4):1735-44. PubMed ID: 24421401
[TBL] [Abstract][Full Text] [Related]
12. Robust presynaptic serotonin 5-HT(1B) receptor inhibition of the striatonigral output and its sensitization by chronic fluoxetine treatment.
Ding S; Li L; Zhou FM
J Neurophysiol; 2015 May; 113(9):3397-409. PubMed ID: 25787955
[TBL] [Abstract][Full Text] [Related]
13. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
Knobelman DA; Hen R; Blendy JA; Lucki I
J Pharmacol Exp Ther; 2001 Sep; 298(3):1092-100. PubMed ID: 11504806
[TBL] [Abstract][Full Text] [Related]
14. Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice.
Shanahan NA; Holick Pierz KA; Masten VL; Waeber C; Ansorge M; Gingrich JA; Geyer MA; Hen R; Dulawa SC
Biol Psychiatry; 2009 Mar; 65(5):401-8. PubMed ID: 19013555
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of action of antidepressant drugs: importance of genetically modified mice in the pharmacological in vivo approach].
Gardier A
Therapie; 2005; 60(5):469-76. PubMed ID: 16433012
[TBL] [Abstract][Full Text] [Related]
16. Sucrose intake and fasting glucose levels in 5-HT(1A) and 5-HT(1B) receptor mutant mice.
Bechtholt AJ; Smith K; Gaughan S; Lucki I
Physiol Behav; 2008 Mar; 93(4-5):659-65. PubMed ID: 18155098
[TBL] [Abstract][Full Text] [Related]
17. 5-HT1B receptor modulation of the serotonin transporter in vivo: studies using KO mice.
Montañez S; Munn JL; Owens WA; Horton RE; Daws LC
Neurochem Int; 2014 Jul; 73():127-31. PubMed ID: 24246466
[TBL] [Abstract][Full Text] [Related]
18. Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice.
Montañez S; Owens WA; Gould GG; Murphy DL; Daws LC
J Neurochem; 2003 Jul; 86(1):210-9. PubMed ID: 12807440
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.
Gardier AM; David DJ; Jego G; Przybylski C; Jacquot C; Durier S; Gruwez B; Douvier E; Beauverie P; Poisson N; Hen R; Bourin M
J Neurochem; 2003 Jul; 86(1):13-24. PubMed ID: 12807420
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice.
Mayorga AJ; Dalvi A; Page ME; Zimov-Levinson S; Hen R; Lucki I
J Pharmacol Exp Ther; 2001 Sep; 298(3):1101-7. PubMed ID: 11504807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
